Rockwell Medical (RMTI) EBITDA Margin: History & Chart

Rockwell Medical, Inc.(RMTI)

Drug Manufacturers - Specialty & Generic · Wixom, MI

$8.28+0.05 (+0.61%)

Delayed quote: Oct 6, 2026, 1:47 PM EDT

About Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Triferic line (Triferic Dialysate and Triferic AVNU), an innovative iron replacement therapy. This therapy is designed to replenish iron and maintain healthy hemoglobin levels in dialysis patients, notably without increasing existing iron stores. Beyond iron management, Rockwell Medical manufactures, sells, and distributes a comprehensive range of hemodialysis concentrates. These include various acid concentrates such as CitraPure (citric), Dri-Sate (dry), and RenalPure (liquid), alongside a dry acid concentrate mixer, and powder bicarbonate concentrates like RenalPure and SteriLyte. These crucial products are vital for sustaining life in dialysis patients by facilitating the removal of toxins and the replacement of essential nutrients in their bloodstream. The company further supplies ancillary items critical for hemodialysis procedures. This extensive catalog comprises blood tubing, fistula needles, dialyzers, pharmaceuticals, specialized component kits, dressings, cleaning agents, filtration salts, and other necessary provisions utilized by hemodialysis providers. Looking to the future, Rockwell Medical is actively developing additional therapeutic candidates. These include treatments for hospitalized individuals suffering from acute heart failure, as well as solutions for home infusion therapy, enabling patients to receive intravenous medications in a home setting. The company primarily serves medium and small-sized dialysis chains, as well as independent dialysis centers. Established in 1996, Rockwell Medical, Inc. maintains its corporate headquarters in Wixom, Michigan.

Wixom, MI

157 employees

www.rockwellmed.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mark Strobeck

View full financials

RMTI EBITDA Margin Metrics

EBITDA MARGIN

-3.61%

EBITDA MARGIN AVG TTM

-4.49%

EBITDA MARGIN AVG 3Y

-2.81%

EBITDA MARGIN AVG 5Y

-9.12%

EBITDA MARGIN AVG 10Y

-29.04%

EBITDA MARGIN AVG 15Y

-34.74%

EBITDA MARGIN AVG 20Y

-29.30%

CURRENT VS TTM AVG

+19.55%

CURRENT VS 3Y AVG

-28.44%

CURRENT VS 5Y AVG

+60.40%

CURRENT VS 10Y AVG

+87.57%

CURRENT VS 15Y AVG

+89.61%

CURRENT VS 20Y AVG

+87.68%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Rockwell Medical, Inc. (RMTI)	$32.68M	-3.61%	-4.49%	-2.81%	-9.12%
Scilex Holding Company (SCLX)vs ›	$32.61M	-884.81%	-512.51%	-340.78%	-266.52%
Aligos Therapeutics, Inc. (ALGS)vs ›	$32.92M	-3982.39%	-3087.93%	-1849.71%	-2051.20%
HeartBeam, Inc. (BEAT)vs ›	$33.30M	31.08%	27.03%	24.58%	21.46%
Accuray Incorporated (ARAY)vs ›	$33.85M	-6.58%	-1.77%	-0.14%	1.64%
Nortech Systems Incorporated (NSYS)vs ›	$31.44M	2.14%	1.67%	3.35%	2.87%
Elutia Inc (ELUT)vs ›	$34.04M	-127.12%	-129.61%	-125.08%	-93.97%
Baird Medical Investment Holdings Limited (BDMD)vs ›	$30.85M	-108.41%	-31.49%	5.24%	21.14%
Grace Therapeutics, Inc. (GRCE)vs ›	$34.58M	-7905.63%	-7905.63%	-7905.63%	-7905.63%
SCYNEXIS, Inc. (SCYX)vs ›	$30.72M	-76.51%	-510.64%	-659.38%	-619.37%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Rockwell Medical, Inc. (RMTI)

$32.68M

-3.61%

-4.49%

-2.81%

-9.12%

Scilex Holding Company (SCLX)vs ›

$32.61M

-884.81%

-512.51%

-340.78%

-266.52%

Aligos Therapeutics, Inc. (ALGS)vs ›

$32.92M

-3982.39%

-3087.93%

-1849.71%

-2051.20%

HeartBeam, Inc. (BEAT)vs ›

$33.30M

31.08%

27.03%

24.58%

21.46%

Accuray Incorporated (ARAY)vs ›

$33.85M

-6.58%

-1.77%

-0.14%

1.64%

Nortech Systems Incorporated (NSYS)vs ›

$31.44M

2.14%

1.67%

3.35%

2.87%

Elutia Inc (ELUT)vs ›

$34.04M

-127.12%

-129.61%

-125.08%

-93.97%

Baird Medical Investment Holdings Limited (BDMD)vs ›

$30.85M

-108.41%

-31.49%

5.24%

21.14%

Grace Therapeutics, Inc. (GRCE)vs ›

$34.58M

-7905.63%

SCYNEXIS, Inc. (SCYX)vs ›

$30.72M

-76.51%

-510.64%

-659.38%

-619.37%

EBITDA Margin FAQ

What is the EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The EBITDA margin for RMTI stock is -3.61%.

Is Rockwell Medical, Inc.'s EBITDA margin high or low?

The EBITDA margin of -3.61% is 60% above its 5-year average of -9.12%, near the high end of its 5-year range (-50.16%–8.75%).

What is the TTM average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The TTM average EBITDA margin for RMTI stock is -4.49%.

What is the 3Y average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The 3Y average EBITDA margin for RMTI stock is -2.81%.

What is the 5Y average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The 5Y average EBITDA margin for RMTI stock is -9.12%.

What is the 10Y average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The 10Y average EBITDA margin for RMTI stock is -29.04%.

What is the 15Y average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The 15Y average EBITDA margin for RMTI stock is -34.74%.

What is the 20Y average EBITDA margin for Rockwell Medical, Inc. (RMTI)?

The 20Y average EBITDA margin for RMTI stock is -29.30%.

DATE	EBITDA MARGIN
2026-06-30	-3.20%
2026-03-31	-5.59%
2025-12-31	0.81%
2025-09-30	-9.56%
2025-06-30	-4.89%
2025-03-31	-4.34%
2024-12-31	0.10%
2024-09-30	8.75%
2024-06-30	4.12%
2024-03-31	-3.44%
2023-12-31	0.01%
2023-09-30	-4.93%
2023-06-30	-15.43%
2023-03-31	-6.44%
2022-12-31	-6.82%
2022-09-30	-19.07%
2022-06-30	-23.24%
2022-03-31	-40.24%
2021-12-31	-50.16%
2021-09-30	-39.82%
2021-06-30	-47.53%
2021-03-31	-42.45%
2020-12-31	-49.37%
2020-09-30	-40.20%
2020-06-30	-31.75%
2020-03-31	-47.01%
2019-12-31	-43.65%
2019-09-30	-47.29%
2019-06-30	-65.21%
2019-03-31	-52.34%
2018-12-31	-54.83%
2018-09-30	-28.87%
2018-06-30	-81.43%
2018-03-31	-43.95%
2017-12-31	-61.27%
2017-09-30	-33.50%
2017-06-30	-49.76%
2017-03-31	-33.09%
2016-12-31	-37.96%
2016-09-30	-35.62%
2016-06-30	-40.08%
2016-03-31	-32.33%
2015-12-31	-41.39%
2015-09-30	-16.49%
2015-06-30	-18.94%
2015-03-31	-25.97%
2014-12-31	-33.17%
2014-09-30	-20.88%
2014-06-30	-16.37%
2014-03-31	-52.21%
2013-12-31	-52.09%
2013-09-30	-92.51%
2013-06-30	-88.75%
2013-03-31	-122.72%
2012-12-31	-103.28%
2012-09-30	-139.05%
2012-06-30	-96.53%
2012-03-31	-86.47%
2011-12-31	-73.19%
2011-09-30	-40.40%
2011-06-30	-36.39%
2011-03-31	-20.07%
2010-12-31	-10.32%
2010-09-30	-2.85%
2010-06-30	2.92%
2010-03-31	-0.24%
2009-12-31	-1.03%
2009-09-30	-8.54%
2009-06-30	-10.82%
2009-03-31	-11.56%
2008-12-31	-20.77%
2008-09-30	-16.78%
2008-06-30	-7.68%
2008-03-31	-9.31%
2007-12-31	-6.74%
2007-09-30	-1.56%
2007-06-30	-2.31%
2007-03-31	-15.17%
2006-12-31	-10.52%
2006-09-30	-19.58%
2006-06-30	-23.79%
2006-03-31	-1.12%
2005-12-31	-0.11%
2005-09-30	4.88%
2005-06-30	3.72%
2005-03-31	3.36%
2004-12-31	4.99%
2004-09-30	6.23%
2004-06-30	5.74%
2004-03-31	6.26%
2003-12-31	6.79%
2003-09-30	5.89%
2003-06-30	2.05%
2003-03-31	1.68%
2002-12-31	1.37%
2002-09-30	-1.31%

DATE

EBITDA MARGIN

2026-06-30

-3.20%

2026-03-31

-5.59%

2025-12-31

0.81%

2025-09-30

-9.56%

2025-06-30

-4.89%

2025-03-31

-4.34%

2024-12-31

0.10%

2024-09-30

8.75%

2024-06-30

4.12%

2024-03-31

-3.44%

2023-12-31

0.01%

2023-09-30

-4.93%

2023-06-30

-15.43%

2023-03-31

-6.44%

2022-12-31

-6.82%

2022-09-30

-19.07%

2022-06-30

-23.24%

2022-03-31

-40.24%

2021-12-31

-50.16%

2021-09-30

-39.82%

2021-06-30

-47.53%

2021-03-31

-42.45%

2020-12-31

-49.37%

2020-09-30

-40.20%

2020-06-30

-31.75%

2020-03-31

-47.01%

2019-12-31

-43.65%

2019-09-30

-47.29%

2019-06-30

-65.21%

2019-03-31

-52.34%

2018-12-31

-54.83%

2018-09-30

-28.87%

2018-06-30

-81.43%

2018-03-31

-43.95%

2017-12-31

-61.27%

2017-09-30

-33.50%

2017-06-30

-49.76%

2017-03-31

-33.09%

2016-12-31

-37.96%

2016-09-30

-35.62%

2016-06-30

-40.08%

2016-03-31

-32.33%

2015-12-31

-41.39%

2015-09-30

-16.49%

2015-06-30

-18.94%

2015-03-31

-25.97%

2014-12-31

-33.17%

2014-09-30

-20.88%

2014-06-30

-16.37%

2014-03-31

-52.21%

2013-12-31

-52.09%

2013-09-30

-92.51%

2013-06-30

-88.75%

2013-03-31

-122.72%

2012-12-31

-103.28%

2012-09-30

-139.05%

2012-06-30

-96.53%

2012-03-31

-86.47%

2011-12-31

-73.19%

2011-09-30

-40.40%

2011-06-30

-36.39%

2011-03-31

-20.07%

2010-12-31

-10.32%

2010-09-30

-2.85%

2010-06-30

2.92%

2010-03-31

-0.24%

2009-12-31

-1.03%

2009-09-30

-8.54%

2009-06-30

-10.82%

2009-03-31

-11.56%

2008-12-31

-20.77%

2008-09-30

-16.78%

2008-06-30

-7.68%

2008-03-31

-9.31%

2007-12-31

-6.74%

2007-09-30

-1.56%

2007-06-30

-2.31%

2007-03-31

-15.17%

2006-12-31

-10.52%

2006-09-30

-19.58%

2006-06-30

-23.79%

2006-03-31

-1.12%

2005-12-31

-0.11%

2005-09-30

4.88%

2005-06-30

3.72%

2005-03-31

3.36%

2004-12-31

4.99%

2004-09-30

6.23%

2004-06-30

5.74%

2004-03-31

6.26%

2003-12-31

6.79%

2003-09-30

5.89%

2003-06-30

2.05%

2003-03-31

1.68%

2002-12-31

1.37%

2002-09-30

-1.31%

EBITDA Margin: -3.61%

RMTI EBITDA Margin

RMTI Average EBITDA Margin Chart

RMTI Current vs Average EBITDA Margin Chart

RMTI EBITDA Margin Metrics

RMTI Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

RMTI EBITDA Margin History

Related Metrics